Memis Dilek, Hekimoglu Sevtap, Sezer Atakan, Altaner Semsi, Sut Necdet, Usta Ufuk
Department of Anesthesiology, Trakya University Medical Faculty, Edirne, Turkey.
Nutrition. 2008 Nov-Dec;24(11-12):1133-8. doi: 10.1016/j.nut.2008.06.008. Epub 2008 Aug 26.
Curcumin has antioxidant, antitumor, and anti-inflammatory properties. However, it remains unknown whether curcumin has any protective effects on sepsis. The purpose of this study was to demonstrate whether curcumin prevents organ dysfunction in animals with sepsis.
Rats were randomized into four groups. The control group (group I, n = 7) did not receive any treatment. The curcumin group (group II, n = 10) only received 1.2 g/kg of curcumin. Escherichia coli were injected into the remaining groups intraperitoneally after general anesthesia. Five hours after injection, 12 rats received placebo (group III), and 10 rats received 1.2 g/kg of curcumin (group IV) for 7 d. All rats were sacrificed on postsepsis day 8 and a midline laparotomy was performed. Livers, kidneys, and small bowels were excised for evaluation of the degree of inflammation and tissue alterations histopathologically.
In the liver, widespread hydropic degeneration of hepatocytes were seen in the sepsis group. There was no hydropic degeneration of hepatocytes and no portal inflammation in the sepsis/curcumin group. With respect to the small bowel, the sepsis group showed edema and prominent intraepithelial infiltration of neutrophil leucocytes and plasma cells. Inflammation and hyperemia in the lamina propria in the sepsis/curcumin group were less than those in the sepsis group. With respect to the kidneys, the sepsis group showed severe acute tubular necrosis that was more restricted in the sepsis/curcumin group than in the sepsis group.
Curcumin reduced organ dysfunction in rats with experimentally formed sepsis. We propose that curcumin may be useful in the therapy of organ dysfunction due to sepsis, shock, and other diseases associated with local or systemic inflammation.
姜黄素具有抗氧化、抗肿瘤和抗炎特性。然而,姜黄素对脓毒症是否具有任何保护作用仍不清楚。本研究的目的是证明姜黄素是否能预防脓毒症动物的器官功能障碍。
将大鼠随机分为四组。对照组(I组,n = 7)未接受任何治疗。姜黄素组(II组,n = 10)仅接受1.2 g/kg的姜黄素。在全身麻醉后,向其余组腹腔内注射大肠杆菌。注射后5小时,12只大鼠接受安慰剂(III组),10只大鼠接受1.2 g/kg的姜黄素(IV组),持续7天。所有大鼠在脓毒症发生后第8天处死,并进行中线剖腹术。切除肝脏、肾脏和小肠,通过组织病理学评估炎症程度和组织改变。
在肝脏方面,脓毒症组可见广泛的肝细胞水样变性。脓毒症/姜黄素组未见肝细胞水样变性,也无门静脉炎症。在小肠方面,脓毒症组表现为水肿以及中性粒细胞和浆细胞显著的上皮内浸润。脓毒症/姜黄素组固有层的炎症和充血程度低于脓毒症组。在肾脏方面,脓毒症组表现为严重的急性肾小管坏死,脓毒症/姜黄素组的坏死程度比脓毒症组更局限。
姜黄素减轻了实验性脓毒症大鼠的器官功能障碍。我们认为姜黄素可能对治疗由脓毒症、休克及其他与局部或全身炎症相关疾病引起的器官功能障碍有用。